文献速递鼻科

血管内栓塞治疗鼻出血

Endovascular Embolization in the Treatment of Epistaxis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2019-02-12

本回顾性病例系列纳入2005至2015年在三级医院因鼻出血接受血管内栓塞(EE)的54例患者共64次就诊,即时止血率92.6%,但短期和长期再出血率较高,作者认为转诊行EE的患者属高危群体,应严密监测再出血等并发症。

要点

  • EE即时止血率为92.6%,但25.4%的患者1周内再出血。
  • 9.8%的患者1周后再出血,主要并发症率为7.4%。
  • 作者认为转诊行EE的患者为再出血和并发症高危群体。

核心结论

  • EE治疗鼻出血的即时成功率与文献相当,但该选定人群中短期和长期再出血率较高。
  • 结果提示转诊行EE的患者为再出血和并发症风险增加的高危群体。
  • 作者认为接受EE的鼻出血患者应严密监测包括再出血在内的并发症。

研究设计与样本

  • 回顾性病例系列,纳入2005至2015年因鼻出血接受EE的患者病历。
  • 共54例患者、64次独立就诊;男性66.7%,平均年龄64.5岁。
  • 出血性疾病占18.8%,高血压占71.7%,61.1%使用抗凝/抗血小板药物。
  • 研究地点为三级医院。

主要发现

  • 即时止血率为92.6%。
  • 3例在EE后1周内死亡并排除后续分析。
  • 剩余患者中64.7%无进一步鼻出血发作。
  • 13例(25.4%)在1周内再出血,其中11例需再次EE或手术止血。
  • 5例(9.8%)在术后超过1周再出血,其中4例需再次EE或手术止血。

临床怎么用

  • 作者认为接受EE的鼻出血患者应严密监测包括再出血在内的并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The cost-effectiveness of endovascular embolization (EE) for intractable epistaxis has been questioned, especially as endoscopic surgical techniques have become standard of care at many institutions. Our objectives were to review the safety profile and effectiveness of EE for epistaxis. STUDY DESIGN: Retrospective case series. SETTING: Tertiary care hospital. SUBJECTS: There were 54 patients and 64 unique encounters. Patients were 66.7% male, with a mean age of 64.5 years. Bleeding disorders were present in 18.8%, hypertension was present in 71.7%, and 61.1% were on anticoagulant/platelet drugs. METHODS: Charts of patients undergoing EE for epistaxis between 2005 and 2015 were retrospectively reviewed. RESULTS: The immediate bleeding control rate was 92.6%. Three patients died within 1 week of EE and were excluded from further analysis. Overall, 64.7% of the remaining patients had no further episodes of epistaxis. Thirteen patients (25.4%) rebled within 1 week, 11 of whom required repeat EE or operative control. Five patients (9.8%) rebled more than 1 week following the procedure with 4 requiring repeat EE or operative control. The major complication rate was 7.4% and included transient stroke, diplopia, facial skin necrosis, and extraperitoneal hemorrhage. CONCLUSION: While the immediate success rate of EE for epistaxis was comparable to the literature, the overall short- and long-term rebleed rate was high in this selected population. The results suggest that patients who are referred for EE represent a high-risk group with increased risk of repeat hemorrhage and morbidity. Patients who undergo EE for epistaxis should be carefully monitored for complications, including repeat hemorrhage.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Huyett P, Jankowitz BT, Wang EW, et al. Endovascular Embolization in the Treatment of Epistaxis. Otolaryngol Head Neck Surg. 2019. PMID: 30744478. doi:10.1177/0194599819829743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。